Join Quintiles at the Disruptive Innovations US conference, September 20-21 and receive 25% off registration with discount code QUINT25. Disruptive Innovations US is a strategic conference dedicated to the advancement of clinical trials by identifying innovative approaches to drug development that will greatly enhance patient experiences and ultimately bring more drugs to the market faster.

Adrian McKemey, SVP, Quintiles Advisory Services, will participate on the “Disrupting Clinical Operations from the CRO Perspective” panel discussing how CROs will distinguish themselves and support innovation in clinical trials.